Safety and quality update: November 2022
16 November 2022
New this month: safety alerts; Choosing Wisely transition, sugammadex and anaphylaxis; cosmetic surgery consultation; webAIRS reported incidents milestone.
- The TGA has listed a shortage of Dantrolene from 4 November 2022 till 10 February 2023
- BD Connecta Stopcock with extension tube - 100 cm recalled due to rupture in the unit blister packaging resulting in potential defect in the sterility of the product.
- Vancomycin 500mg vial recall due to out of specification stability results which do not meet the shelf-life specification for potency.
See all safety alerts
Choosing Wisely transition
NPS MedicineWise will be transitioning their programs to other organisations as their grant funding is coming to an end. As a consequence of this, Choosing Wisely will be transitioning to Australian Commission of Safety and Quality in Health Care.
Sugammadex and anaphylaxis
A recent coronial inquest in New South Wales concerning the death of a previously well 22-year-old male accepted as being caused by anaphylaxis to sugammadex. Associate Professor Joanna Sutherland, Chair of ANZCA Safety and Quality Committee wrote a letter to the Therapeutic Goods Administration to improve reporting of serious adverse events for sugammadex and explore any additional activities that we could develop collaboratively to prevent avoidable harm associated with sugammadex.
Medical Board of Australia cosmetic surgery consultation
Following on from earlier consultations this year, the Medical Board of Australia is consulting on three reforms to make cosmetic surgery safer. Three draft documents are open for comment: a registration standard to establish an endorsement pathway, stronger guidelines for medical practitioners who perform cosmetic surgery, and advertising guidelines for cosmetic surgery. Further information is available on Ahpra’s cosmetic surgery hub.
10,000 incidents reported to webAIRS
The webAIRS incident reporting system has collected over 10,000 reports from 2009 onwards, and an overview was presented at the recent Combined Scientific Congress in Wellington in October. The detailed results of an analysis of the medication errors, and the recent Advisory Notices to Anaesthetists (ANA) application on the webAIRS website were also discussed. Are you contributing to quality anaesthesia? To register visit webAIRS.
ADS-ANZCA Perioperative Diabetes and Hyperglycaemia Guidelines (Adults)
In support of World Diabetes Day, the Australian Diabetes Society (ADS) has announced the release of the revised ADS-ANZCA Perioperative Diabetes and Hyperglycaemia Guidelines (Adults). ANZCA fellows Dr Roger Traill, Professor David Story, Dr Nathan Davis, Dr Judy Killen and Dr Amy Lawrence collaborated with the ADS in the revision of these important guidelines.